Cytotoxic activity of quassinoids from Eurycoma longifolia

Natural Product Communications

Volumn 5, Issue 7, 2010, Pages 1009-1012

  Miyake, Katsunori ^a   Li, Feng ^a   Tezuka, Yasuhiro ^a   Awale, Suresh ^a   Kadota, Shigetoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cytotoxicity; Eurycoma longifolia; Quassinoids

Indexed keywords

DOXORUBICIN; EURYCOMA LONGIFOLIA EXTRACT; EURYCOMALACTONE; LAURYCOLACTONE A; LAURYCOLACTONE B; QUASSINOID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; QUASSINOID DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LUNG ADENOCARCINOMA; MELANOMA B16; NEOPLASM; NONHUMAN; ANIMAL; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; EURYCOMA; MOUSE; TUMOR CELL LINE;

EURYCOMA LONGIFOLIA; MURINAE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; EURYCOMA; HUMANS; MICE; MOLECULAR STRUCTURE; QUASSINS;

EID: 77956620625     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1000500704     Document Type: Article

References (13)

1. Cavalli F. (2008) The world cancer declaration: a roadmap for change. Lancet Oncology, 9, 810-811.
2. Moore MA, Sobue T. (2009) Cancer research and control activities in Japan: contributions to international efforts. Asian Pacific Journal of Cancer Prevention, 10, 183-200.
3. Ministry of Health Labour and Welfare. 〈http://www.mhlw.go.jp/ english/database/db-hw/populate/pop1-t1.html/〉 Trends in leading causes of death, accessed 22 January, 2010.
4. Ueda J-Y, Tezuka Y, Banskota AH, Le Tran Q, Tran QK, Harimaya Y, Saiki I, Kadota S. (2002) Antiproliferative activity of vietnamese medicinal plants. Biological & Pharmaceutical Bulletin, 25, 753-760. (Pubitemid 40036711)
5. Miyake K, Tezuka Y, Awale S, Li F, Kadota S. (2009) Quassinoids from Eurycoma longifolia. Journal of Natural Products, 72, 2135-2140.
6. Ohnishi Y, Sakamoto T, Fujii H, Kimura F, Murata J, Tazawa K, Fujimaki M, Sato Y, Kondo M, Une Y, Uchino J, Saiki I. (1997) Characterization of a liver metastatic variant of murine colon 26 carcinoma cells. Tumor Biology, 18, 113-122. (Pubitemid 27096399)
7. Hart IR. (1979) The selection and characterization of an invasive variant of the B16 melanoma. American Journal of Pathology, 97, 587-600. (Pubitemid 10175784)
8. Aptekman PM, Lewis MR. (1951) Evidence of resistance to tumor graft in early stages of induced oncolysis. Journal of Immunology, 66, 361-364.
9. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. Journal of the National Cancer Institute, 51, 1417-1423.
10. Balis FM, Holcenberg JS, Bleyer WA. (1983) Clinical pharmacokinetics of commonly used anticancer drugs. Clinical Pharmacokinetics, 8, 202-232. (Pubitemid 13134066)
11. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A, Boyd MR. (1990) Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Journal of the National Cancer Institute, 82, 1113-1118. (Pubitemid 20213251)
12. Li F, Awale S, Zhang H, Tezuka Y, Esumi H, Kadota S. (2009) Chemical Constituents of Propolis from Myanmar and Their Preferential Cytotoxicity against a Human Pancreatic Cancer Cell Line. Journal of Natural Products, 72, 1283-1287.
13. Saito K, Oku T, Ata N, Miyashiro H, Hattori M, Saiki I. (1997) A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors. Biological & Pharmaceutical Bulletin, 20, 345-348. (Pubitemid 27212990)